Atypical Antipsychotics May Dysregulate Immune Response, Increase Risk for COVID-19
Short- to intermediate-term exposure to atypical antipsychotic medications may dysregulate adaptive immune responses, increasing susceptibility to respiratory infections like COVID-19.